Tourmaline BioTRML

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Dr. Sandeep C. Kulkarni, M.D.

$402.1M

Market Cap • 26/04/2024

2021

(há 3 anos)
Fundação

2023

(1 year ago)
IPO

NASDAQ

Listagem
Flag of US

New York

Sede • New York

Valuation

Valuation Indicators

Retorno Histórico

TRMLSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

4%

1 dia

23/04/2024

1%

1 semana

19/04/2024

-34%

1 mês

26/03/2024

10 anos

Histórico